Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

April 01, 1994; Volume 269,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abou-Donia, M B

    1. You have access
      Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
      R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;
  2. Adams, M L

    1. You have access
      Effects of nitric oxide-related agents on rat testicular function.
      M L Adams, E R Meyer, B N Sewing and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;
  3. Adamson, G M

    1. You have access
      Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes.
      G M Adamson and R E Billings
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 367-373;
  4. Agresta, C A

    1. You have access
      Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;
  5. Aicher, L

    1. You have access
      Developmental expression of human microsomal epoxide hydrolase.
      C J Omiecinski, L Aicher and L Swenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 417-423;
  6. Albiero, R

    1. You have access
      Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;
  7. Alford, G E

    1. You have access
      A novel phospholipase C inhibitor and phorbol esters reveal selective regulation of thrombin- and parathyroid hormone-stimulated signaling pathways in rat osteosarcoma cells.
      M Babich, G E Alford and R A Nissenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 172-177;
  8. Alper, R H

    1. You have access
      Adrenergic and nonadrenergic regulation of hindlimb blood flow during stress in rats.
      R H Alper and M H Zink
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 305-312;
  9. Anderson, C B

    1. You have access
      Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
      M J Mangino, M K Murphy and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 75-81;
  10. Anderson, J K

    1. You have access
      Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
      R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;
  11. Ardid, D

    1. You have access
      Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;
  12. Artibani, W

    1. You have access
      ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
  13. Asaad, M

    1. You have access
      Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;
  14. Aumaitre, O

    1. You have access
      Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;
  15. Azim, S

    1. You have access
      Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

B

  1. Babich, M

    1. You have access
      A novel phospholipase C inhibitor and phorbol esters reveal selective regulation of thrombin- and parathyroid hormone-stimulated signaling pathways in rat osteosarcoma cells.
      M Babich, G E Alford and R A Nissenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 172-177;
  2. Bakry, N

    1. You have access
      Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
      L L Simpson, J A Coffield and N Bakry
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 256-262;
  3. Barzago, M M

    1. You have access
      Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;
  4. Belknap, J K

    1. You have access
      Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
      J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;
  5. Benishin, C G

    1. You have access
      Inhibition of a K+ current by beta-dendrotoxin in primary and subcultured vascular smooth muscle cells.
      J Ren, E Karpinski and C G Benishin
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 209-214;
  6. Bervoets, K

    1. You have access
      5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
      K Bervoets and M J Millan
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 110-120;
    2. You have access
      5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;
  7. Betoin, F

    1. You have access
      Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;
  8. Bianchi, R G

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  9. Biggio, G

    1. You have access
      Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;
  10. Billings, R E

    1. You have access
      Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes.
      G M Adamson and R E Billings
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 367-373;
  11. Billman, G E

    1. You have access
      The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
      G E Billman
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 409-416;
  12. Bombardt, P A

    1. You have access
      Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
      P A Bombardt, J E Brewer and M G Johnson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 145-150;
  13. Bonati, M

    1. You have access
      Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;
  14. Bongiorno, A

    1. You have access
      Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;
  15. Bortolotti, A

    1. You have access
      Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;
  16. Brewer, J E

    1. You have access
      Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
      P A Bombardt, J E Brewer and M G Johnson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 145-150;
  17. Butelman, E R

    1. You have access
      In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;
  18. Bymaster, F P

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

C

  1. Calligaro, D O

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  2. Calpista, A

    1. You have access
      ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
  3. Canton, H

    1. You have access
      5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;
  4. Carter, D B

    1. You have access
      Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;
  5. Casler, J J

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  6. Castle, N A

    1. You have access
      K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
      M T Slawsky and N A Castle
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 66-74;
  7. Chamienia, A L

    1. You have access
      Renal functional responses to the 5-HT1A receptor agonist flesinoxan: effects of controlled renal perfusion pressure.
      A L Chamienia and E J Johns
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 215-220;
  8. Chan, J K

    1. You have access
      Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;
  9. Chao, C C

    1. You have access
      Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;
  10. Chavin, J

    1. You have access
      Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;
  11. Chi, S

    1. You have access
      Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
      T A Kosten, M J Miserendino, S Chi and E J Nestler
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;
  12. Chiodo, L A

    1. You have access
      Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
      J Zhang, L A Chiodo and A S Freeman
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 313-321;
  13. Chow, F S

    1. You have access
      Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
      W Piekoszewski, F S Chow and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 103-109;
  14. Ciaccio, M

    1. You have access
      Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;
  15. Cicero, T J

    1. You have access
      Effects of nitric oxide-related agents on rat testicular function.
      M L Adams, E R Meyer, B N Sewing and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;
  16. Cifani, J R

    1. You have access
      Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;
  17. Clair, P

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  18. Coffield, J A

    1. You have access
      Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
      L L Simpson, J A Coffield and N Bakry
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 256-262;
  19. Collins, P W

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  20. Colombo, T

    1. You have access
      Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
      T Colombo, M Zucchetti and M D'Incalci
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 22-27;
  21. Cooke, L

    1. You have access
      Differences in beta adrenergic receptor agonist affinity between cardiac myocytes and coronary arterioles in canine heart.
      L Cooke and K H Muntz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 351-357;
  22. Cooley, A J

    1. You have access
      Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;
  23. Corcoran, J J

    1. You have access
      Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
      R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;
  24. Corsi, M

    1. You have access
      ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
  25. Cossum, P A

    1. You have access
      Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;
  26. Crabbe, J C

    1. You have access
      Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
      J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;
  27. Crawshaw, L I

    1. You have access
      Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
      J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;
  28. Crooke, S T

    1. You have access
      Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;
  29. Cuccheddu, T

    1. You have access
      Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;
  30. Curi-Pedrosa, R

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

D

  1. D'Incalci, M

    1. You have access
      Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
      T Colombo, M Zucchetti and M D'Incalci
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 22-27;
  2. Daujat, M

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  3. Dho, L

    1. You have access
      A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;
  4. Domergue, J

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  5. Dubey, R K

    1. You have access
      Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
      R K Dubey
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 402-408;
  6. Duchene-Marullaz, P

    1. You have access
      Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;
  7. Duescher, R J

    1. You have access
      Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;

E

  1. Efrati, S

    1. You have access
      Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;
  2. Elfarra, A A

    1. You have access
      Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;
  3. Endou, M

    1. You have access
      Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
      M Endou, E Poli and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 221-229;
  4. Eschalier, A

    1. You have access
      Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

F

  1. Fenton, R L

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  2. Floris, S

    1. You have access
      Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;
  3. Fourtanier, G

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  4. Freeman, A S

    1. You have access
      Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
      J Zhang, L A Chiodo and A S Freeman
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 313-321;
  5. Fuller, R W

    1. You have access
      Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
      R W Fuller, S K Hemrick-Luecke and H D Snoddy
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 132-136;

G

  1. Gaviraghi, G

    1. You have access
      ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
    2. You have access
      Quantification of the calcium antagonism of lacidipine by kinetic analysis.
      A Giacometti, D Micheli, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;
  2. Gekker, G

    1. You have access
      Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;
  3. Gervot, L

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  4. Ghiani, C A

    1. You have access
      Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;
  5. Giacometti, A

    1. You have access
      Quantification of the calcium antagonism of lacidipine by kinetic analysis.
      A Giacometti, D Micheli, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;
  6. Giacomini, K M

    1. You have access
      Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;
  7. Giusti, P

    1. You have access
      Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;
  8. Gobert, A

    1. You have access
      5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;
  9. Greenwood, B

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;

H

  1. Hamilton, B J

    1. You have access
      Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;
  2. Hemrick-Luecke, S K

    1. You have access
      Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
      R W Fuller, S K Hemrick-Luecke and H D Snoddy
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 132-136;
  3. Herbet, A

    1. You have access
      Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;
  4. Hermsmeyer, K

    1. You have access
      Resting state block and use independence of rat vascular muscle Ca++ channels by Ro 40-5967.
      S K Mishra and K Hermsmeyer
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 178-183;
  5. Herzer, W A

    1. You have access
      Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
      C K Kost, W A Herzer, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;
  6. Hu, S

    1. You have access
      Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;
  7. Huff, R A

    1. You have access
      Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
      R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;
  8. Hui, A C

    1. You have access
      Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;

I

  1. Imagawa, J

    1. You have access
      In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;
  2. Itoh, J

    1. You have access
      Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
      J Itoh, M Ukai and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 15-21;

J

  1. Jackson, E K

    1. You have access
      Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
      C K Kost, W A Herzer, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;
  2. Johns, E J

    1. You have access
      Renal functional responses to the 5-HT1A receptor agonist flesinoxan: effects of controlled renal perfusion pressure.
      A L Chamienia and E J Johns
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 215-220;
  3. Johnson, M G

    1. You have access
      Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
      P A Bombardt, J E Brewer and M G Johnson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 145-150;
  4. Joyeux, H

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  5. Jusko, W J

    1. You have access
      Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
      W Piekoszewski, F S Chow and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 103-109;

K

  1. Kalivas, P W

    1. You have access
      Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
      M A Klitenick and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 437-448;
  2. Kamei, K

    1. You have access
      In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;
  3. Kameyama, T

    1. You have access
      Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
      J Itoh, M Ukai and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 15-21;
  4. Kang, Y S

    1. You have access
      Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
      Y S Kang and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 344-350;
  5. Karpinski, E

    1. You have access
      Inhibition of a K+ current by beta-dendrotoxin in primary and subcultured vascular smooth muscle cells.
      J Ren, E Karpinski and C G Benishin
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 209-214;
  6. Kelly, G

    1. You have access
      Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;
  7. Kemeny, J L

    1. You have access
      Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;
  8. Khairallah, P A

    1. You have access
      Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;
  9. Klitenick, M A

    1. You have access
      Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
      M A Klitenick and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 437-448;
  10. Koga, T

    1. You have access
      In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;
  11. Kost, C K

    1. You have access
      Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
      C K Kost, W A Herzer, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;
  12. Kosten, T A

    1. You have access
      Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
      T A Kosten, M J Miserendino, S Chi and E J Nestler
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;
  13. Kowalski, D L

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  14. Kurata, Y

    1. You have access
      Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;

L

  1. Lash, L H

    1. You have access
      Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;
  2. Lavarenne, J

    1. You have access
      Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;
  3. Layer, R T

    1. You have access
      Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;
  4. Lesca, P

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  5. Levi, R

    1. You have access
      Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
      M Endou, E Poli and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 221-229;
  6. Levitt, D G

    1. You have access
      The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol.
      M D Levitt and D G Levitt
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 297-304;
  7. Levitt, M D

    1. You have access
      The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol.
      M D Levitt and D G Levitt
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 297-304;
  8. Lewis, J W

    1. You have access
      In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;
  9. Li, P

    1. You have access
      Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
      C K Kost, W A Herzer, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;
  10. Livrea, M A

    1. You have access
      Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;
  11. Long, J B

    1. You have access
      Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;
  12. Lucchini, G

    1. You have access
      Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;

M

  1. Malfatto, G

    1. You have access
      Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
      A Zaza, G Malfatto and P J Schwartz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 336-343;
  2. Mangino, M J

    1. You have access
      Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
      M J Mangino, M K Murphy and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 75-81;
  3. Maresi, E

    1. You have access
      Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;
  4. Marini, A M

    1. You have access
      The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
      M Weller, A M Marini, B Martin and S M Paul
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;
  5. Markham, P M

    1. You have access
      Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;
  6. Marszalec, W

    1. You have access
      Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;
  7. Martin, B

    1. You have access
      The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
      M Weller, A M Marini, B Martin and S M Paul
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;
  8. Martinez-Arizala, A

    1. You have access
      Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;
  9. McGrath, M P

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  10. Meyer, E R

    1. You have access
      Effects of nitric oxide-related agents on rat testicular function.
      M L Adams, E R Meyer, B N Sewing and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;
  11. Micheli, D

    1. You have access
      Quantification of the calcium antagonism of lacidipine by kinetic analysis.
      A Giacometti, D Micheli, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;
  12. Millan, M J

    1. You have access
      5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
      K Bervoets and M J Millan
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 110-120;
    2. You have access
      5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;
  13. Milovanovic, M

    1. You have access
      Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;
  14. Miserendino, M J

    1. You have access
      Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
      T A Kosten, M J Miserendino, S Chi and E J Nestler
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;
  15. Mishra, S K

    1. You have access
      Resting state block and use independence of rat vascular muscle Ca++ channels by Ro 40-5967.
      S K Mishra and K Hermsmeyer
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 178-183;
  16. Mitch, C H

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  17. Mitchell, S R

    1. You have access
      Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
      J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;
  18. Molinoff, P B

    1. You have access
      Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
      C D Unsworth and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 246-255;
  19. Moravec, C S

    1. You have access
      Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;
  20. Motzo, C

    1. You have access
      Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;
  21. Muntz, K H

    1. You have access
      Differences in beta adrenergic receptor agonist affinity between cardiac myocytes and coronary arterioles in canine heart.
      L Cooke and K H Muntz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 351-357;
  22. Murphy, M K

    1. You have access
      Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
      M J Mangino, M K Murphy and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 75-81;

N

  1. Nabata, H

    1. You have access
      In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;
  2. Nagata, K

    1. You have access
      Dual action of the cyclodiene insecticide dieldrin on the gamma-aminobutyric acid receptor-chloride channel complex of rat dorsal root ganglion neurons.
      K Nagata and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 164-171;
  3. Narahashi, T

    1. You have access
      Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;
    2. You have access
      Dual action of the cyclodiene insecticide dieldrin on the gamma-aminobutyric acid receptor-chloride channel complex of rat dorsal root ganglion neurons.
      K Nagata and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 164-171;
  4. Nestler, E J

    1. You have access
      Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
      T A Kosten, M J Miserendino, S Chi and E J Nestler
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;
  5. Nissenson, R A

    1. You have access
      A novel phospholipase C inhibitor and phorbol esters reveal selective regulation of thrombin- and parathyroid hormone-stimulated signaling pathways in rat osteosarcoma cells.
      M Babich, G E Alford and R A Nissenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 172-177;
  6. Niwano, Y

    1. You have access
      Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
      A Sanbe, K Tanonaka, Y Niwano and S Takeo
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;
  7. Nowak, G

    1. You have access
      Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;

O

  1. Olesen, P H

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  2. Oleshansky, M A

    1. You have access
      Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;
  3. Omarini, D

    1. You have access
      Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;
  4. Omiecinski, C J

    1. You have access
      Developmental expression of human microsomal epoxide hydrolase.
      C J Omiecinski, L Aicher and L Swenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 417-423;
  5. Ott, R J

    1. You have access
      Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;
  6. Ourlin, J C

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  7. Owens, S R

    1. You have access
      Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;

P

  1. Palea, S

    1. You have access
      ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
  2. Pardridge, W M

    1. You have access
      Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
      Y S Kang and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 344-350;
  3. Patrono, C

    1. You have access
      A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;
  4. Paul, I A

    1. You have access
      Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;
  5. Paul, S M

    1. You have access
      The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
      M Weller, A M Marini, B Martin and S M Paul
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;
  6. Perkins, W E

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  7. Peterson, P K

    1. You have access
      Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;
  8. Pichard, L

    1. You have access
      Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  9. Piekoszewski, W

    1. You have access
      Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
      W Piekoszewski, F S Chow and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 103-109;
  10. Pietra, C

    1. You have access
      ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
  11. Poli, E

    1. You have access
      Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
      M Endou, E Poli and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 221-229;
  12. Popik, P

    1. You have access
      Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;
  13. Puniak, M A

    1. You have access
      Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

R

  1. Ramanathan, V K

    1. You have access
      Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;
  2. Ren, J

    1. You have access
      Inhibition of a K+ current by beta-dendrotoxin in primary and subcultured vascular smooth muscle cells.
      J Ren, E Karpinski and C G Benishin
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 209-214;
  3. Rigamonti, D D

    1. You have access
      Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;
  4. Rimoldi, O

    1. You have access
      A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;
  5. Rivet, J M

    1. You have access
      5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;
  6. Rogers, W L

    1. You have access
      Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;
  7. Ruhe, T

    1. You have access
      Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;

S

  1. Salvati, P

    1. You have access
      A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;
  2. Salzman, S K

    1. You have access
      Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;
  3. Sanbe, A

    1. You have access
      Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
      A Sanbe, K Tanonaka, Y Niwano and S Takeo
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;
  4. Sausen, P J

    1. You have access
      Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;
  5. Sawyer, B D

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
  6. Schoepp, D D

    1. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  7. Schwartz, P J

    1. You have access
      Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
      A Zaza, G Malfatto and P J Schwartz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 336-343;
  8. Serra, M

    1. You have access
      Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;
  9. Sewing, B N

    1. You have access
      Effects of nitric oxide-related agents on rat testicular function.
      M L Adams, E R Meyer, B N Sewing and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;
  10. Seymour, A A

    1. You have access
      Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;
  11. Shannon, H E

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  12. Shea, J P

    1. You have access
      Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;
  13. Sheardown, M J

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  14. Sheldon, J H

    1. You have access
      Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;
  15. Sheng, W S

    1. You have access
      Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;
  16. Simpson, L L

    1. You have access
      Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
      L L Simpson, J A Coffield and N Bakry
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 256-262;
  17. Sirover, M A

    1. You have access
      New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells.
      J C Wurzer, R J Tallarida and M A Sirover
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 39-43;
  18. Skolnick, P

    1. You have access
      Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;
  19. Slawsky, M T

    1. You have access
      K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
      M T Slawsky and N A Castle
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 66-74;
  20. Smith, P L

    1. You have access
      Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;
  21. Snoddy, H D

    1. You have access
      Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
      R W Fuller, S K Hemrick-Luecke and H D Snoddy
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 132-136;
  22. Sonsalla, P K

    1. You have access
      The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
      I Terleckyj and P K Sonsalla
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 44-50;
  23. Stellari, F F

    1. You have access
      Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;
  24. Stolzenbach, J C

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  25. Sugo, I

    1. You have access
      In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;
  26. Suzdak, P D

    1. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  27. Swenson, L

    1. You have access
      Developmental expression of human microsomal epoxide hydrolase.
      C J Omiecinski, L Aicher and L Swenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 417-423;

T

  1. Takeo, S

    1. You have access
      Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
      A Sanbe, K Tanonaka, Y Niwano and S Takeo
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;
  2. Tallarida, R J

    1. You have access
      New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells.
      J C Wurzer, R J Tallarida and M A Sirover
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 39-43;
  3. Tanonaka, K

    1. You have access
      Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
      A Sanbe, K Tanonaka, Y Niwano and S Takeo
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;
  4. Terleckyj, I

    1. You have access
      The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
      I Terleckyj and P K Sonsalla
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 44-50;
  5. Tesoriere, L

    1. You have access
      Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;
  6. Tremont, S J

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  7. Trist, D G

    1. You have access
      ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
    2. You have access
      Quantification of the calcium antagonism of lacidipine by kinetic analysis.
      A Giacometti, D Micheli, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;
  8. Truong, L

    1. You have access
      Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;
  9. Tsang, M

    1. You have access
      Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;

U

  1. Ukai, M

    1. You have access
      Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
      J Itoh, M Ukai and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 15-21;
  2. Ukmar, G

    1. You have access
      A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;
  3. Unsworth, C D

    1. You have access
      Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
      C D Unsworth and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 246-255;

V

  1. Vaga, L

    1. You have access
      A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;
  2. Valenza, M

    1. You have access
      Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;
  3. Veiga, S

    1. You have access
      5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;

W

  1. Wagner, G M

    1. You have access
      Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  2. Walker, E A

    1. You have access
      In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;
  3. Wang, L

    1. You have access
      Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;
  4. Ward, J S

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  5. Weller, M

    1. You have access
      The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
      M Weller, A M Marini, B Martin and S M Paul
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;
  6. Wingfield, C P

    1. You have access
      Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;
  7. Wong, D T

    1. You have access
      Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. You have access
      Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  8. Woods, J H

    1. You have access
      In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;
  9. Wurzer, J C

    1. You have access
      New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells.
      J C Wurzer, R J Tallarida and M A Sirover
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 39-43;

Y

  1. Yoshida, S

    1. You have access
      In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;

Z

  1. Zaza, A

    1. You have access
      Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
      A Zaza, G Malfatto and P J Schwartz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 336-343;
  2. Zernig, G

    1. You have access
      In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;
  3. Zhang, J

    1. You have access
      Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
      J Zhang, L A Chiodo and A S Freeman
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 313-321;
  4. Zink, M H

    1. You have access
      Adrenergic and nonadrenergic regulation of hindlimb blood flow during stress in rats.
      R H Alper and M H Zink
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 305-312;
  5. Zucchetti, M

    1. You have access
      Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
      T Colombo, M Zucchetti and M D'Incalci
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 22-27;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 269, Issue 1
1 Apr 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics